Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
Review of prostate cancer prevention study shows no benefit for use of selenium and vitamin E supplements
National Cancer Institute, 12/23/08
Lippman SM et al. - In a study to assess the use of selenium and vitamin E supplements in prevention of prostate cancer, it was shown that selenium and vitamin E supplements, taken either alone or together, did not prevent prostate cancer.
Methods- Men were randomly assigned to take 1 of 4 sets of supplements or placebos, with more than 8000 men in each group.
- One group took both selenium and vitamin E; one took selenium and a vitamin E placebo; one took vitamin E and a selenium placebo; and the final group received placebos of both supplements.
- 5-year rate of prostate cancer diagnosis in the 4 arms of the study was 4.43% in the placebo arm, 4.56% in the selenium arm, 4.93% in the vitamin E arm (the highest rate, not a statistically significant difference from the placebo arm), and 4.56% in the selenium plus vitamin E arm.
- There was a small but not statistically significant increase in the number of prostate cancer cases among the over 35,000 men age 50 and older in the trial taking only vitamin E.
- There was a small, but not statistically significant, increase in the number of cases of adult-onset diabetes in men taking only selenium (10% for those taking selenium vs 9.3% taking placebo).
Related Articles
Risk of dying from prostate cancer in men randomized to screening
Cancer, 10/13/09
Relevance Score: 72%
Validation in a Multiple Urology Practice Cohort of the Prostate Cancer Prevention Trial Calculator for Predicting Prostate Cancer Detection
The Journal of Urology, 11/13/09
Relevance Score: 71%
A prospective study of lifetime physical activity and prostate cancer incidence and mortality
British Journal of Cancer, 11/02/09
Relevance Score: 71%
Association of 17 prostate cancer susceptibility loci with prostate cancer risk in Chinese men
The Prostate, 11/02/09
Relevance Score: 71%
Prostate specific antigen for early detection of prostate cancer: longitudinal study
British Medical Journal, 10/08/09
Relevance Score: 71%
Today in Alternative Therapies...keeping you current
Receive free subspecialty "5-minute updates" via email
Trick or treat? Australian newspaper portrayal of complementary and alternative medicine for the treatment of cancer
Supportive Care in Cancer, 12/12/09
Efficacy of Goshajinkigan for Peripheral Neurotoxicity of Oxaliplatin in Patients with Advanced or Recurrent Colorectal Cancer
Evidence-based Complementary and Alternative Medicine , 12/02/09
Guggulsterone enhances head and neck cancer therapies via inhibition of signal transducer and activator of transcription-3
Carcinogenesis, 12/01/09
Today in Renal/Urologic...keeping you current
Receive free subspecialty "5-minute updates" via email
Any proportion of ductal adenocarcinoma in radical prostatectomy specimens predicts extraprostatic extension
Human Pathology, 12/19/09
Papillary renal cell carcinoma with diffuse clear cells and thyroid-like macrofollicular areas
Annals of Diagnostic Pathology, 12/19/09
Diagnostic value of fibronectin and mutant p53 in the urine of patients with bladder cancer: impact on clinicopathological features and disease recurrence
Medical Oncology, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


